Dr. Gerich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000Fax+1 303-724-1891
Education & Training
University of ColoradoFellowship, Gastroenterology, 2008 - 2011
University of California Davis HealthResidency, Internal Medicine, 2004 - 2007
McGill University Faculty of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2005 - Present
CO State Medical License 2007 - 2025- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
- Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease Start of enrollment: 2014 Feb 01
- Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD) Start of enrollment: 2022 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 294 citationsMicrobiota-Derived Indole Metabolites Promote Human and Murine Intestinal Homeostasis through Regulation of Interleukin-10 ReceptorErica E. Alexeev, Jordi M. Lanis, Daniel J. Kao, Eric L. Campbell, Caleb J. Kelly
The American Journal of Pathology. 2018-05-01 - 33 citationsFunctional intraepithelial lymphocyte changes in inflammatory bowel disease and spondyloarthritis have disease specific correlations with intestinal microbiotaEmilie Regner, Neha Ohri, Andrew Stahly, Mark E. Gerich, Blair Fennimore
Arthritis Research & Therapy. 2018-07-20 - 31 citationsProspective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intr...Benjamin L Cohen, Phillip Fleshner, Sunanda V Kane, Hans H Herfarth, Nicole Palekar
Gastroenterology. 2022-07-01
Journal Articles
- Functional Intraepithelial Lymphocyte Changes in Inflammatory Bowel Disease and Spondyloarthritis Have Disease Specific Correlations with Intestinal MicrobiotaLiron Caplan, Daniel N Frank, Blair P Fennimore, Mark E Gerich, Emilie H Regner, Kristine A Kuhn, BioMed Central
Press Mentions
Vitality Biopharma : Appoints New Clinical AdvisorsMay 3rd, 2017
Cannabis in Gastroenterology: Physicians Lack Answers as Patient Interest PeaksSeptember 21st, 2017
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
